Rovati A - Search Results

1

The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).

Gobbi PG, Broglia C, Valentino F, Mammi C, Lombardo M, Merli F, Luminari S, Polimeno G, Riezzo A, Lambelet P, Rovati A, Corazza GR, Federico M; Gruppo Italiano Studio Linfomi. Gobbi PG, et al. Among authors: rovati a. Ann Oncol. 2006 Apr;17(4):676-82. doi: 10.1093/annonc/mdl002. Epub 2006 Jan 30. Ann Oncol. 2006. PMID: 16446317 Free article. Clinical Trial.

2

Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.

Cazzola M, Ponchio L, Pedrotti C, Farina G, Cerani P, Lucotti C, Novella A, Rovati A, Bergamaschi G, Beguin Y. Cazzola M, et al. Among authors: rovati a. Haematologica. 1996 Sep-Oct;81(5):434-41. Haematologica. 1996. PMID: 8952157 Free article.

3

Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.

Vercesi E, Cerani P, Rolandi V, Rovati A, Bergamaschi G. Vercesi E, et al. Among authors: rovati a. Haematologica. 2000 Aug;85(8):787-91. Haematologica. 2000. PMID: 10942923

4

Red blood cell precursor mass as an independent determinant of serum erythropoietin level.

Cazzola M, Guarnone R, Cerani P, Centenara E, Rovati A, Beguin Y. Cazzola M, et al. Among authors: rovati a. Blood. 1998 Mar 15;91(6):2139-45. Blood. 1998. PMID: 9490701 Free article.

5

The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis.

Rovati A, Bergamaschi G, Casula S, Cerani P, Grasso M, Cazzola M. Rovati A, et al. Haematologica. 1999 Feb;84(2):182-3. Haematologica. 1999. PMID: 10091420 No abstract available.

6

Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment.

Cazzola M, Guarnone R, Cerani P, Rovati A, Ascari E. Cazzola M, et al. Among authors: rovati a. Blood. 1998 Jan 1;91(1):360-1. Blood. 1998. PMID: 9414308 Free article. No abstract available.

7

Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder.

Cazzola M, Cerani P, Rovati A, Iannone A, Claudiani G, Bergamaschi G. Cazzola M, et al. Among authors: rovati a. Blood. 1998 Oct 15;92(8):2979-81. Blood. 1998. PMID: 9763590 Free article. No abstract available.

8

Successful pregnancy following gonadotropin therapy in a young female with juvenile idiopathic hemochromatosis and secondary hypogonadotropic hypogonadism.

Farina G, Pedrotti C, Cerani P, Rovati A, Strada E, Bergamaschi G, Montanari L. Farina G, et al. Among authors: rovati a. Haematologica. 1995 Jul-Aug;80(4):335-7. Haematologica. 1995. PMID: 7590503

9

Psychological Support in a COVID-19 Hospital: A Community Case Study.

Rizzi D, Asperges E, Rovati A, Bigoni F, Pistillo E, Corsico A, Mojoli F, Perlini S, Bruno R. Rizzi D, et al. Among authors: rovati a. Front Psychol. 2022 Feb 17;12:820074. doi: 10.3389/fpsyg.2021.820074. eCollection 2021. Front Psychol. 2022. PMID: 35250697 Free PMC article.

10

Exploring the Effects of Cancer as a Traumatic Event on Italian Adolescents and Young Adults: Investigating Psychological Well-Being, Identity Construction and Coping Strategies.

Ionio C, Bigoni F, Sacchi M, Zecca M, Bergami E, Landoni M, Ciuffo G, Rovati A, Rizzi D. Ionio C, et al. Among authors: rovati a. Pediatr Rep. 2023 Mar 22;15(1):254-262. doi: 10.3390/pediatric15010021. Pediatr Rep. 2023. PMID: 36976728 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters